About 4 500 reports

  • Gastrointestinal Drugs Market Trends And Strategies
  • TRANEXAMIC ACID TO TREAT GASTROINTESTINAL BLEEDING

The gastrointestinal diseases drugs market covers medicines used for the treatment of ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors,...

  • Pathology
  • World
  • Market Size
  • Allergan plc
  • Novo Nordisk Group
  • GASTROINTESTINAL DISORDERS, EU5 AND US, EPIDEMIOLOGY OF GASTROINTESTINAL
  • shows that for each of the three key indications, the composition by stage of

Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape Summary Gastrointestinal disorders are common, and a number of them have a large patient population. Across the seven major markets (the US, the UK, France,...

  • Pathology
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

Global Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017 ##.

  • Pathology
  • France
  • United States
  • World
  • Forecast

Global Market Study on Gastrointestinal Stromal Tumor: Stomach Indications to Account for Largest Revenue Share during 2017-2026 ##.

  • Cancer
  • Healthcare
  • Pathology
  • World
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Pathology
  • France
  • Germany
  • United States
  • Market Shares
  • RESPIRATORY DISEASES
  • METABOLIC DISORDERS DRUGS

The Business Research Company The Business Research Company July 2018 February 2018 Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ##

  • Pathology
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Information on the leading companies in this market is given below.
  • RESPIRATORY DISEASES

The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases.Pharmaceutical companies produce both generic and branded drugs. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Pharmaceutical drugs are intended for human or...

  • Pathology
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

Gastrointestinal Stromal Tumor (GIST) - Epidemiology Forecast to 2027 ##.

  • Pathology
  • France
  • Germany
  • Italy
  • Spain

Europe Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017 ##.

  • Pathology
  • Europe
  • France
  • Germany
  • Italy

Drug A: Company ## ##. ##. ##.

  • Cancer
  • Pathology
  • United States
  • Market Shares
  • 6.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
  • GLOBAL - GASTROINTESTINAL CANCER LIQUID BIOPSY MARKET (MILLION US$), 2015 - 2017

The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...

  • Pathology
  • World
  • Forecast
  • Market Size
  • MDxHealth SA
  • Market definition
  • ECONOMIC BURDEN OF MAJOR DIGESTIVE DISEASES IN THE US 2014 ($ BILLIONS)

About Capsule Endoscopes Capsule endoscopy is a painless technique to evaluate gastrointestinal disorders such as obscure gastrointestinal bleeding, inflammatory bowel disease, ulcerative colitis, celiac disease, polyposis syndrome, small bowel tumor, and colon cancer. Capsule endoscopy is an eight-hour-long procedure, in which...

  • Pathology
  • World
  • IntroMedic
  • Medtronic, Inc.
  • Olympus Corporation
  • 7.2 GASTROINTESTINAL TUMOR MODELS
  • GASTROINTESTINAL TUMOR MODELS IS EXPECTED TO ACCOUNT FOR THE

PDX models market is projected to grow at a CAGR of 16.7% The global PDX models market is estimated to grow at a CAGR of 16.7% from 2017 to 2022, to reach USD 167.6 million. The key factors driving the growth of the overall PDX models market include the growing demand for personalized medicine, continuous support for cancer...

  • Pathology
  • United States
  • Charles River Laboratories International, Inc.
  • Horizon Discovery
  • WuXi AppTec Co.

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Pathology
  • France
  • Germany
  • Italy
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • United States
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Japan
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Italy
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • France
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Germany
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • United Kingdom
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Spain
  • Market Shares

SUPPLIER POWER - LOW ##.

  • Pathology
  • Pharmaceutical
  • Pharmacy
  • Retail
  • Specialty Store
  • U.K PHARMACEUTICAL PACKAGING EQUIPMENT MARKET

SUPPLIER POWER - LOW ##.

  • Manufacturing
  • Packaging
  • Pathology
  • Pharmaceutical
  • Pharmaceutical Packaging
  • GASTROINTESTINAL CANCERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
  • Untitled

Radiation is one of the most common treatments for cancer and may be delivered by a machine outside the body (external-beam radiation therapy), or it may be delivered by a radioactive material placed in the body near cancer cells (internal radiation therapy/ brachytherapy), or by systemic radiation therapy which uses radioactive substances,...

  • Pathology
  • World
  • Market Size
  • Accuray Incorporated
  • Elekta Group
  • SAFETY OF HERCEPTIN MONOTHERAPY IN EARLY-STAGE HER2-POSITIVE BREAST CANCER
  • SAFETY PROFILE OF HALAVEN IN THE THIRD-LINE TREATMENT OF METASTATIC BREAST CANCER

ipage=##& xml=##& quest=##& rid=##& section=##& sequence=-##& pdf=##& dn=## [Accessed February ##, 2017].

  • Pathology
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • KEY EVENTS AND TRENDS TO WATCH FOR IN RESPIRATORY AND GASTROINTESTINAL DISEASES
  • KEY EVENTS AND TRENDS TO WATCH FOR IN GASTROINTESTINAL CANCERS

The Biopharmaceutical Industry in 2018: Key Events and Trends to Watch for by Therapy Area Summary GlobalData’s "The Biopharmaceutical Industry in 2018: Key Events and Trends to Watch for by Therapy Area", provides an insight-rich overview of the key events and trends that our analysts expect to...

  • Pathology
  • United States
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group
  • VERISANTE CORE - GASTROINTESTINAL CANCER
  • VERISANTE CORE - GASTROINTESTINAL CANCER - PRODUCT DESCRIPTION

Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for...

  • Cancer
  • Pathology
  • Canada
  • GlobalData's company
  • Verisante Technology, Inc.
  • Digestive/Gastrointestinal System Procedures
  • Digestive/Gastrointestinal System Procedures

Surgical Procedure Volumes: Global Analysis, an essential tool for healthcare business planners, provides surgical procedure volume data in a geographic context. The report looks at surgery trends with an in-depth analysis of growth drivers and inhibitors, including world population growth, aging demographics, lifestyle indicators, growing...

  • Health Services
  • Hospital
  • Pathology
  • World
  • Forecast
  • 7.1.2.1.2 GASTROINTESTINAL INFECTIONS
  • North American Microbiology Testing Market - By Disease Area (2017 - 2022) (in USD million)

Microbiology Testing Market The Global Microbiology Testing Market The market is estimated to be USD XX million in 2016 and is expected to reach USD XX million by 2022, growing at a CAGR of XX% during the forecast period. Microbiology testing is a rapidly growing segment of the in-vitro diagnostics industry and is used to check for contamination...

  • Pathology
  • North America
  • United States
  • World
  • Alere Inc.
  • GLOBAL CLINICAL NUTRITION MARKET, BY DISEASE TYPE, (2018 TO 2023) (IN USD MILLION)
  • CLINICAL NUTRITION MARKET: REVENUE IN USD MILLION, BY DISEASE TYPE, GLOBAL, 2018-2023

GASTROINTESTINAL DISORDER IS ONE OF THE MOST COMMON DISORDERS IN THE AGED POPULATION, WHO REQUIRE CLINICAL NUTRITION AS SUPPLEMENT TO MAINTAIN THE BODY-ENERGY BALANCE.

  • Pathology
  • World
  • Market Size
  • Baxter International Inc.
  • Fresenius Group